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1. INTRODUCTION 
The study of binding of neurotensin molecule 
(NT, tridecapeptide pGlu’-Leu2-Tyr3-Glu4- 
Asn5 - Lys6-Pro7-Arg8-Arg9-Pro’o-Tyr11-Ile12 
-Leu13), of its analogues and fragments, as well as 
of several other peptide bioregulators to rat mast 
cells [l-3] has shown that xenopsin (XE, octapep- 
tide pGlu’-Gly2-Lys3-Arg4-Pro’-Trp6-Ile’ 
-Leu*) and bradykinin (BK, nonapeptide Arg’- 
Pro’- Pro3- Gly4- Phe5- Ser6- Pro’- Phe*- Arg’) 
compete successfully with neurotensin for the 
binding, whereas 15 other peptides are devoid of 
this property [2]. A comparable and relatively high 
(&-loo nM) level of specific binding to the same 
type of receptors observed for different peptides is 
a rather unusual example of peptide ligand- 
receptor interaction; it is legitimate to assume that 
one of the reasons responsible for such an effect is 
the similarity shared by some primary sequence 
elements and especially ‘binding conformations’ of 
NT, XE and BK molecules. The data concerning 
the three-dimensional structure of NT, XE and BK 
molecules necessary for their comparison can be 
provided by means of energy calculations; it must 
be noted that no experimental evidence as to the 
conformations of NT and XE molecules is 
available so far. 
[4] and [5], respectively. Given below are the 
calculation results obtained for the NT molecule; 
the calculation procedures and the potential func- 
tions used were as in [4-71. The general calculation 
pattern was essentially as for wMSH molecule in 
[6]. During the first two steps, the ‘model decapep- 
tide’ Glu4-Ala’-Ly@-Pro’- Arg’- Arg’- Pro”- 
Ala1’-Ala’2-Ala13 containing all ionogenic 
groups of the molecule and the N-terminal pen- 
tapeptide pGlu’-Leu2-Tyr3-Glu4-Asn’ were con- 
sidered. Finally energy calculations were perform- 
ed for all possible combinations of low-energy 
backbone structures for the two fragments 
overlapping in positions 4 and 5 of the peptide se- 
quence, conformations of the Glu4 sidechain being 
the same as determined according to the ‘model 
decapeptide’ calculations. This final step (energy 
calculations for -410 structures of the whole NT 
molecule) was accompanied by the refinement of 
side chain packing for Leu2, Tyr3, Asn’, Tyr”, 
Ile12 and Leu13 residues by means of a specially 
designed algorithm [S]. 
2. METHODS AND RESULTS 
The calculated sets of low-energy backbone 
structures for XE and BK have been described in 
The calculation resulted in 5 types of low-energy 
backbone structures found for the 4-13 fragment, 
which with optimal space orientation of the l-3 
fragment meet the requirement AU = U-c/mi, 5 
10 kcal/mol. These structures are listed in table 1. 
Keeping in mind that the 9-13 fragment possesses 
the same level of affinity to rat mast cell receptors 
as NT molecule itself [3], one can note that only 4 
backbone structure types of this fragment are 
presented in table 1, namely BRBLL, BRRBL, 
BBLLB and BRBLB. 
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Table 1 
Low-energy structures of neurotensin 
March 1983 
Residue Angle Molecular backbone conformationa 
1 2 3 4 5 
pGlu’ 
Leu’ 
Tyr3 
Glu4 
Asn’ 
Lys6 
Pro7 
# 
4 
Xl 
x2 
4 
+ 
Xl 
x2 
x3 
4 
4 
Xl 
x2 
x3 
d 42 37 40 43 43 
* 62 71 62 37 38 
Xl -164 -60 -60 60 59 
x2 81 -80 -80 80 81 
4 
# 
Xl 
x2 
x3 
x4 
-32 151 151 -36 146 Arg’ 
-112 - 123 -119 -138 -133 
141 133 132 129 131 
-11 - 161 - 161 -160 -160 
98 80 81 100 100 
53 - 132 -134 -137 -136 
110 139 142 137 133 
165 -58 -61 -60 -60 
- 101 -80 -81 -80 99 
100 -80 -80 80 80 
44 46 51 56 56 
34 32 29 51 53 
-75 -77 -77 -159 -159 
- 174 179 - 177 -145 -144 
-96 -99 -97 120 138 
- 129 -136 -135 -148 -147 
132 130 131 140 133 
-78 -79 -75 -77 -75 
154 161 163 161 162 
- 178 - 166 -164 -159 -158 
171 176 175 79 77 
-35 -46 -37 - 102 104 
Residue Angle Molecular backbone conformationa 
1 2 3 4 5 
Arg’ 
Pro” 
Tyr” 
Eel2 
Leu13 
4 
bJ 
Xl 
x2 
X3 
x4 
4 
4J 
XI 
x2 
x3 
x4 
4 
4 
!.J 
Xl 
x2 
x3 
4 
$ 
XI 
x2 
4 
G 
X1 
x2 
A U(kcal/mol) 0.0 0.41 10.12 10.21 10.28 
- 114 - 133 - 128 -140 -138 
129 127 129 153 141 
- 141 -139 -148 -11 -76 
-91 -94 -107 160 154 
112 104 109 -164 -168 
139 88 92 -161 179 
- 123 - 128 -122 -137 -177 
151 149 137 138 127 
- 51 -53 -57 57 43 
173 172 152 -166 -152 
-65 -61 -66 -179 -179 
-86 -94 -98 116 140 
-28 -24 - 15 127 -31 
-130 - 127 -99 60 -115 
146 137 -44 134 145 
43 61 -4 -60 40 
85 97 101 100 82 
99 100 80 80 80 
39 37 - 135 45 33 
95 98 98 96 90 
-49 -58 56 -59 -42 
122 100 120 100 120 
48 50 26 -96 -104 
91 96 93 140 145 
-78 - 161 -79 -80 -178 
99 100 100 100 81 
a Symbols B, R and L are used to denote local energy minima of the peptide backbone in B (qj- - 140”, $- 1400), R 
(4--6O”, $- -609, L (qS-60”, $-60”) and H (qS-80°, + - - 80”) regions of potential maps: (1) 
RBLLLBRBBRBLL; (2) BBBLLBRBBRBLL; (3) BBBLLBRBBRRBL; (4) RBBLLBBBBBLLB; (5) 
BBBLLBBBBRBLB 
3. DISCUSSION 
The 9-13 fragment responsible for the binding 
of NT molecule to mast cell receptors contains a 
. . . Pro-X. . . sequence (X is an aromatic amino 
acid residue) which is common for NT, XE and BK 
molecules (see table 2). The data shown in table 2 
allow us to assume that the possible ‘binding site’ 
26 
for NT molecule can be restricted to the 9-12 frag- 
ment only, since the shortening of the peptide 
chain due to omission of one C-terminal residue 
(BK) affects the affinity only insignificantly 
whereas that involving two residues (AT) leads to 
a complete lack of affinity. On the other hand, our 
previous energy calculations for XE [4] and BK [5] 
indicate that the ‘binding site’ conformations of 
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Table 2 
Comparison of amino acid sequences of NT, XE, BK and AT molecules 
Neurotensin 
Xenopsin 
Bradykinin 
Angiotensin= 
(NT) pGIu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr -Be-Leu 
(XE) pGlu-Gly-Lys-Arg-Pro-Trp -Be-Leu 
(BK) Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe -Arg 
(AT) Asp-Arg-Val-Tyr-Be-His-Pro-Phe 
a The only one among 15 peptides discussed in [2] (NT, XE and BK are not included) having a Pro-X sequence in its 
molecule 
b 
Fig.1. A stereo-view of neurotensin structures 1 and 3 (table 1): ( -), site in the molecule directly involved in the 
binding to rat mast cells; (a) conformation of RBL type; (b) conformation of RRB type. 
27 
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BK: 
NT: RBLLLBRB BRBL L * 
BBBLLBRB BRBL L * 
BBBLLBRB BRRB L ** 
RBBLLBBB BBLL B 
BBBLLBBB BRBL B * 
BBBHB BRBB 
BBRRR BRBL * 
BBBHB BRRB ** 
BBBHR BRBB 
BBRRR BBBB 
BBBHR BRRB ** 
BBBHB BRRL 
BBBHR BRBL * 
BBRRB LBBB 
BBBHR BBLB 
BBRRB LRBB 
BBRLR BBBB 
XE: BRB BRBL L * 
BHR BRBL B * 
BRB BBLL B 
BRB BRRB L ** 
BBL LRRB B 
RRB LRRB B 
BRB BRBL B * 
By one and two asterisks are marked conformations with 
the three-dimensional structure of the ‘binding site’ in all 
of three sets of low-energy backbone conformations 
Table 3 
Comparison of the complete sets of low-energy 
backbone conformations for NT, BK [5] and XE [4] 
molecules 
BRBL and BRRB types appear to be common for 
all three peptides in question (table 3). 
However, the biological data obtained for 
various NT analogues with single replacements for 
amino acid enantiomers demonstrate that only 
analogues with replacements in positions IO-12 ex- 
hibit a decreased level of affinity to receptor [3]. 
Therefore, the backbone conformation of B type 
in position 9 (which is sterically hindered for D- 
Arg residue) cannot represent he ‘conformational’ 
factor affecting the tightness of ligand-receptor 
binding. Thus, it may be concluded that tripeptides 
Pro10-Tyr”-Ile12 (NT), Pro’-Trp6-Ile’ (XE) and 
Pro’-Phe’-Arg’ (BK) can possibly be the 
fragments providing a certain complementarity of 
NT, XE and BK molecules to the ‘common’ bind- 
ing site of rat mast cell receptors, their common 
‘binding conformation’ being that of RBL or RRB 
type (fig.la,b). It can be added finally, that the 
general shape of the two proposed ‘binding con- 
formation’ types are essentially the same (fig.1): 
they differ only in the twist by -180” of the pep- 
tide bond plane connecting the second and third 
residues of the binding site of the molecule. 
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